ctDNA Promising for Cancer Detection, but Faces Challenges
CtDNA tests have the potential to identify many cancer types but researchers must assess their efficacy across different racial/ethnic groups.
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CtDNA tests have the potential to identify many cancer types but researchers must assess their efficacy across different racial/ethnic groups.
An oncologist was surprised to see that health insurer WellCare denied approval for a drug she had prescribed within the indication. Before she could appeal, WellCare restarted the review process.
A blood clot was misdiagnosed as sciatica, which led to the loss of a leg and a huge malpractice verdict.
Over the past 30 years, survival of patients with de novo metastatic cancers shows divergent trends, with substantial gains against some cancers but limited or no progress against others.
For nearly 30 years, guidelines have recommended halting cervical screening at age 65, despite limited science. A $3 million NIH study is now underway to settle the question of when it's safe to stop.